Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation

• Post author:
• Post published:June 9, 2025
• Post category:

The clinical application of cell replacement therapy in the US is dependent on the FDA's approval, and the primary objective of the FDA is to protect patients from unsafe drugs…

Continue ReadingEnsuring the safety of cell therapy: a quality control pipeline for cell purification and validation

Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product

• Post author:
• Post published:June 9, 2025
• Post category:

Human embryonic stem cells (hESC), and other related pluripotent stem cells, have great potential as starting material for the manufacture of curative cell therapies. This is primarily for two reasons.…

Continue ReadingMethods for detection and elimination of residual human embryonic stem cells in a differentiated cell product

Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy

• Post author:
• Post published:September 12, 2024
• Post category:

Continue ReadingSafety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy

Global gene expression profiling of single inhibitory neurons derived from human stem cells

• Post author:
• Post published:September 12, 2024
• Post category:

Continue ReadingGlobal gene expression profiling of single inhibitory neurons derived from human stem cells

Autologous therapy for Parkinson’s disease: single cell RNAseq for in depth characterization of transplanted cells

• Post author:
• Post published:September 12, 2024
• Post category:

Continue ReadingAutologous therapy for Parkinson’s disease: single cell RNAseq for in depth characterization of transplanted cells